Cite
APA Citation
Huang, X., Qiu, L., Jin, J., Zhou, D., Chen, X., Hou, M., Hu, J., Hu, Y., Ke, X., Li, J., Liang, Y., Liu, T., Lv, Y., Ren, H., Sun, A., Wang, J., Zhao, C., Salman, M., Sun, S., Howes, A., Wang, J., Wu, P., & Li, J. (n.d.). ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open‐label phase 3 study. Cancer medicine, 7, 1043–1055. http://access.bl.uk/ark:/81055/vdc_100059835921.0x000019